TScan Therapeutics, Inc. - Common Stock (NQ:TCRX)
1.240
+0.110
(+9.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 11, 2025
Add to My Watchlist
Headline News about TScan Therapeutics, Inc. - Common Stock
Via Benzinga

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 26, 2024
Via Benzinga


The Analyst Landscape: 5 Takes On TScan Therapeutics
December 11, 2024
Via Benzinga

Demystifying TScan Therapeutics: Insights From 4 Analyst Reviews
November 06, 2024
Via Benzinga

Via Benzinga

The Analyst Landscape: 7 Takes On TScan Therapeutics
June 04, 2024
Via Benzinga

Via Benzinga



Unveiling 4 Analyst Insights On TScan Therapeutics
April 23, 2024
Via Benzinga



TScan Therapeutics: Q4 Earnings Insights
March 06, 2024
Via Benzinga

Recap: TScan Therapeutics Q3 Earnings
November 09, 2023
Via Benzinga


12 Health Care Stocks Moving In Tuesday's After-Market Session
November 07, 2023
Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 25, 2023
Via Benzinga

Via Benzinga



Via Benzinga

Via Benzinga




Via Benzinga

Via Benzinga

Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free